Treatment-emergent adverse events occurring in ≥ 5% of patients in the etelcalcetide arms, adverse events leading to discontinuation, and serious adverse events.
- Geoffrey A. Block (4631053)
- Glenn M. Chertow (2967792)
- John T. Sullivan (290436)
- Hongjie Deng (6470399)
- Omar Mather (6470402)
- Holly Tomlin (6470405)
- Michael Serenko (6470408)
Publication date
March 2019
DOI Publisher
Public Library of Science (PLoS)Abstract
Treatment-emergent adverse events occurring in ≥ 5% of patients in the etelcalcetide arms, adverse events leading to discontinuation, and serious adverse events.</p
Add to ORKG